ÂÜÀòÂÒÂ×

Dawn Hill is a seasoned leader in the biopharmaceutical industry, currently serving as VP of Global Risk Management and REMS Account Management Lead at Syneos Health since November 2024. With extensive experience in safety risk management and regulatory compliance, Dawn has previously held senior roles at BioMarin Pharmaceutical Inc. and Gilead Sciences, where responsibilities included developing risk management strategies, overseeing REMS programs, and engaging cross-functional teams. Dawn's career also includes significant contributions to corporate giving and patient assistance programs, clinical trial coordination, and research. With an MBA from Rutgers Business School and advanced degrees in immunology and cell biology, Dawn demonstrates a strong educational foundation complemented by a strategic approach to business and regulatory challenges in health care.